Related Experiment Video
Updated: Aug 9, 2026
06:49
Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
Published on: March 14, 2014
[Therapy of onychomycosis]
1Klinika za dermatovenerologiju, Klinicka bolnica, Sestre milosrdnice, Zagreb.
Lijecnicki Vjesnik
|May 1, 1997
Summary
Effective onychomycosis treatment involves combining systemic and topical antifungal agents like amorolfine and terbinafine. This study evaluated 88 patients, finding combination therapy yielded the best results for nail fungus infections.
Area of Science:
- Dermatology
- Mycology
- Pharmacology
Context:
- Onychomycosis, a common fungal nail infection, presents diagnostic and therapeutic challenges.
- Understanding the etiology, clinical presentation, and diagnostic methods is crucial for effective management.
- Current therapeutic strategies vary, necessitating evaluation of their efficacy.
Purpose:
- To review key data on the etiology, clinical signs, diagnostic methods, and treatments for onychomycosis.
- To evaluate the therapeutic outcomes in a 6-month clinical study involving 141 patients with onychomycosis.
- To identify the most effective therapeutic modalities for treating onychomycosis.
Summary:
- A 6-month clinical study registered 141 patients with onychomycosis.
- Data from 88 patients, categorized by clinical findings and treatment, were analyzed.
- Combination therapy with systemic and topical antifungal agents, specifically amorolfine and terbinafine, demonstrated the best therapeutic results.
Impact:
- Provides evidence supporting the efficacy of combination antifungal therapy for onychomycosis.
- Highlights amorolfine and terbinafine as key agents in achieving successful treatment outcomes.
- Informs clinical practice regarding optimal treatment strategies for fungal nail infections.
Related Concept Videos
01:23Skin Diseases and Disorders
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:20Candidiasis
Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
01:31Diabetic Foot Ulcer
Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...